Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Trop Med Int Health ; 29(4): 327-333, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38348585

ABSTRACT

OBJECTIVES: Cutaneous hyperpigmentation is one of the main adverse effects encountered in patients undergoing leprosy treatment with multidrug therapy (WHO-MDT). This adverse effect has been described as intolerable and capable of contributing to social stigma. The objectives of this study were to quantify the variation in skin colour induced by clofazimine during and after treatment and to assess the related stigma. METHODS: This observational cross-sectional study objectively measured skin colour in 51 patients by reading the individual typology angle (ITA°) with a spectrophotometer, followed by the application of the Stigma Scale of the Explanatory Model Interview Catalogue (EMIC). RESULTS: Skin hyperpigmentation was observed in 100% of the individuals. They showed more negative ITA° values in lesion areas than non-lesion areas, particularly in sun-exposed regions. Clofazimine-induced cutaneous hyperpigmentation was not homogeneous and seemed to follow the lesion locations. The mean EMIC score was 18.8 points. CONCLUSION: All patients presented skin hyperpigmentation caused by clofazimine, detectable through spectrophotometry. Hyperpigmentation strongly impacted the social domain, indicating the intersectionality of disease and skin colour stigma, contributing to the social isolation of these patients. Health authorities should consider the negative impact of clofazimine on treatment adherence.


Subject(s)
Hyperpigmentation , Leprosy , Humans , Clofazimine/adverse effects , Leprostatic Agents/adverse effects , Cross-Sectional Studies , Social Stigma , Drug Therapy, Combination , Leprosy/drug therapy , Leprosy/etiology , Hyperpigmentation/chemically induced , Hyperpigmentation/drug therapy , Hyperpigmentation/pathology
2.
Mem Inst Oswaldo Cruz ; 112(12): 822-828, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29211243

ABSTRACT

OBJECTIVES: Show that hidden endemic leprosy exists in a municipality of inner São Paulo state (Brazil) with active surveillance actions based on clinical and immunological evaluations. METHODS: The study sample was composed by people randomly selected by a dermatologist during medical care in the public emergency department and by active surveillance carried out during two days at a mobile clinic. All subjects received a dermato-neurological examination and blood sampling to determine anti-PGL-I antibody titers by enzyme-linked immunosorbent assay (ELISA). RESULTS: From July to December 2015, 24 new cases of leprosy were diagnosed; all were classified as multibacillary (MB) leprosy, one with severe Lucio's phenomenon. Seventeen (75%) were found with grade-1 or 2 disability at the moment of diagnosis. Anti-PGL-I titer was positive in 31/133 (23.3%) individuals, only 6/24 (25%) were positive in newly diagnosed leprosy cases. CONCLUSIONS: During the last ten years before this study, the average new case detection rate (NCDR) in this town was 2.62/100,000 population. After our work, the NCDR was raised to 42.8/100,000. These results indicate a very high number of hidden leprosy cases in this supposedly low endemic area of Brazil.


Subject(s)
Antibodies, Bacterial/blood , Leprosy/epidemiology , Mycobacterium leprae/immunology , Adolescent , Adult , Aged , Brazil/epidemiology , Endemic Diseases , Enzyme-Linked Immunosorbent Assay , Female , Humans , Leprosy/diagnosis , Male , Mass Screening , Middle Aged , Young Adult
3.
Mem. Inst. Oswaldo Cruz ; 112(12): 822-828, Dec. 2017. tab, graf
Article in English | LILACS | ID: biblio-894859

ABSTRACT

OBJECTIVES Show that hidden endemic leprosy exists in a municipality of inner São Paulo state (Brazil) with active surveillance actions based on clinical and immunological evaluations. METHODS The study sample was composed by people randomly selected by a dermatologist during medical care in the public emergency department and by active surveillance carried out during two days at a mobile clinic. All subjects received a dermato-neurological examination and blood sampling to determine anti-PGL-I antibody titers by enzyme-linked immunosorbent assay (ELISA). RESULTS From July to December 2015, 24 new cases of leprosy were diagnosed; all were classified as multibacillary (MB) leprosy, one with severe Lucio's phenomenon. Seventeen (75%) were found with grade-1 or 2 disability at the moment of diagnosis. Anti-PGL-I titer was positive in 31/133 (23.3%) individuals, only 6/24 (25%) were positive in newly diagnosed leprosy cases. CONCLUSIONS During the last ten years before this study, the average new case detection rate (NCDR) in this town was 2.62/100,000 population. After our work, the NCDR was raised to 42.8/100,000. These results indicate a very high number of hidden leprosy cases in this supposedly low endemic area of Brazil.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Enzyme-Linked Immunosorbent Assay , Leprosy/diagnosis , Leprosy/epidemiology , Antibodies, Bacterial/blood , Mycobacterium leprae/immunology , Brazil/epidemiology , Mass Screening , Endemic Diseases
4.
Rev. Inst. Med. Trop. Säo Paulo ; Rev. Inst. Med. Trop. Säo Paulo;46(1): 33-36, Jan.-Feb. 2004. ilus
Article in English | LILACS | ID: lil-356655

ABSTRACT

Este trabalho demonstra o isolamento de Fonsecaea pedrosoi de espinhos da planta Mimosa pudica L., a partir do local de suposta infecção identificado pela paciente infectada. O diagnóstico clínico de cromoblastomicose foi estabelecido pelo achado de corpos fumagóides no exame microscópico direto e pelas culturas de F. pedrosoi do material obtido da lesão da paciente. A mesma espécie foi isolada da paciente e da planta. A microscopia eletrônica de transmissão da superfície dos espinhos evidenciou a disposição conidial característica de F. pedrosoi. Estes dados indicam que a planta M. pudica deve ser uma fonte natural de infecção do fungo F. pedrosoi.


Subject(s)
Adult , Female , Humans , Ascomycota/isolation & purification , Chromoblastomycosis/microbiology , Mimosa/microbiology , Chromoblastomycosis/diagnosis , Microscopy, Electron, Scanning , Mimosa/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL